Intersections Inc.
INTX News Today: Stay Updated with the Latest Intersections Inc. News in Real Time
Find INTX news now at Meyka AI. Stay informed with the latest Intersections Inc. stocks updates, including price news, market analysis, and expert insights.
Pre-market $11.57: UiPath (PATH) NYSE on 17 Mar 2026 sees AI margin gains
Pre-market PATH stock at $11.57 on 17 Mar 2026 with Meyka AI forecast and analyst notes
Oppenheimer Maintains Outperform on CytomX Therapeutics (CTMX) March 2026
Oppenheimer maintains Outperform on CytomX. CTMX analyst rating maintained with PT $12 and Meyka AI grade B+
ZBH.SW down 4.26% pre-market on SIX: Zimmer Biomet faces near-term support test
Pre-market: ZBH.SW stock drops to CHF67.50 on SIX; Meyka AI forecast and technicals point to downside risk
Cowen Maintains Buy on TransMedics Group, Inc. (TMDX) March 2026
Cowen maintains Buy on TransMedics; TMDX analyst rating held Buy on March 16, 2026
CHM.CN Waverunner Capital (CNQ) at C$0.05 on 17 Mar 2026: High-volume move signals liquidity shift
CHM.CN stock jumps to C$0.05 on CNQ 17 Mar 2026; high-volume mover analysis, valuation and Meyka forecast
ECOX (Eco Innovation Group PNK) up 11.11% to $0.002 on 17 Mar 2026: Watch heavy volume and liquidity
ECOX stock up 11.11% to $0.002 on 17 Mar 2026. Volume 516,353,928. Active penny stock with high RSI and mixed fundamentals.
BofA Maintains Neutral on Baxter International Inc. (BAX) March 2026
BofA maintains Neutral on Baxter. Read the BAX analyst rating, implications, and market context
Raymond James Maintains Strong Buy for Cogent Biosciences (COGT) March 2026
Raymond James reiterates Strong Buy for Cogent; COGT analyst rating held on March 16, 2026 with market implications
Wolfe Research Maintains Outperform on BioMarin (BMRN) March 16, 2026
Wolfe Research maintains Outperform for BioMarin; BMRN analyst rating review and investor implications